AB Sciex LLC:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:AB Sciex LLC - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10453
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AB Sciex LLC (Sciex), a subsidiary of Danaher Corp, is a provider of life science analytical technologies. The company provides mass spectrometry solutions combined with capillary electrophoresis and liquid chromatography. Its product portfolio includes liquid chromatography-mass spectrometers (LC-MS) and related hardware, software and consumables; capillary electrophoresis systems; and high-performance liquid chromatography (HPLC) systems. The company’s solutions find application in clinical research and diagnostics, biologics, capillary electrophoresis, genetic analysis, drug discovery and development, environmental testing, food and beverage testing, and forensic toxicology. The company serves clinical laboratory analysts, and research scientists in scientific discovery and diagnostic outcomes. It has operations in the Americas, Europe, Asia, Middle East and Australia. Sciex is headquartered in Framingham, Massachusetts, the US.

AB Sciex LLC – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AB Sciex LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AB Sciex LLC, Medical Equipment Deals By Type, 2012 to YTD 2018 6
AB Sciex LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AB Sciex LLC, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
AB Sciex LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
AB Sciex LLC, Medical Equipment, Deal Details 10
Partnerships 10
Prosolia Enters Into Licensing Agreement With AB Sciex For ORNL Analytical Technology 10
AB Sciex Enters into Co-Marketing Agreement with IROA Technologies 11
SCIEX forms Joint Venture with Zhejiang Dian Diagnostics in China 12
AB Sciex Enters into Agreement with QPS Holdings 13
AB Sciex Enters into Co-Marketing Agreement with Pressure BioSciences 14
Ab Sciex Enters into Co-Marketing Agreement with Hepregen 15
Ab Sciex Enters into Co-Development Agreement with Dalton Pharma 16
Ab Sciex, Genedata And Leco Enter Into Agreement For Metabolomics Data Analysis Solution 17
AB Sciex LLC – Key Competitors 18
AB Sciex LLC – Key Employees 19
AB Sciex LLC – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 22
Product News 22
Jan 24, 2017: SCIEX Launches New X500B QTOF Mass Spectrometry System for Standardized Biotherapeutic Characterization 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
AB Sciex LLC, Medical Equipment, Key Facts 2
AB Sciex LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
AB Sciex LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AB Sciex LLC, Medical Equipment Deals By Type, 2012 to YTD 2018 6
AB Sciex LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AB Sciex LLC, Deals By Market, 2012 to YTD 2018 8
AB Sciex LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Prosolia Enters Into Licensing Agreement With AB Sciex For ORNL Analytical Technology 10
AB Sciex Enters into Co-Marketing Agreement with IROA Technologies 11
SCIEX forms Joint Venture with Zhejiang Dian Diagnostics in China 12
AB Sciex Enters into Agreement with QPS Holdings 13
AB Sciex Enters into Co-Marketing Agreement with Pressure BioSciences 14
Ab Sciex Enters into Co-Marketing Agreement with Hepregen 15
Ab Sciex Enters into Co-Development Agreement with Dalton Pharma 16
Ab Sciex, Genedata And Leco Enter Into Agreement For Metabolomics Data Analysis Solution 17
AB Sciex LLC, Key Competitors 18
AB Sciex LLC, Key Employees 19
AB Sciex LLC, Other Locations 20
AB Sciex LLC, Subsidiaries 20

List of Figures
AB Sciex LLC, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
AB Sciex LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
AB Sciex LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
AB Sciex LLC, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
AB Sciex LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AB Sciex LLC, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
AB Sciex LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AB Sciex LLC, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[AB Sciex LLC:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AMEWAS, Inc.:企業の戦略・SWOT・財務分析
    AMEWAS, Inc. - Strategy, SWOT and Corporate Finance Report Summary AMEWAS, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Singulex Inc:医療機器:M&Aディール及び事業提携情報
    Summary Singulex Inc (Singulex) is a medical device company develops single molecule counting technology. The company provides Sgx clarity system, an in vitro diagnostics platform that provides high sensitivity next generation immunodiagnostics. Its proprietary SMC technology allows scientists and p …
  • Dechra Pharmaceuticals PLC:企業のM&A・事業提携・投資動向
    Dechra Pharmaceuticals PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dechra Pharmaceuticals PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Citius Pharmaceuticals Inc (CTXR):企業の財務・戦略的SWOT分析
    Summary Citius Pharmaceuticals Inc (Citius), formerly Trail One Inc is a specialty pharmaceutical company that focuses on the development and commercialization of anti-infective products in adjunct cancer care, and critical care drug products. The company’s proprietary product candidates include Min …
  • Kathmandu Holdings Limited:企業の戦略・SWOT・財務分析
    Kathmandu Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Kathmandu Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Randox Laboratories Ltd:企業の製品パイプライン分析2018
    Summary Randox Laboratories Ltd (Randox) is a clinical diagnostic company that manufactures and provides clinical diagnostic solutions to laboratories. The company’s products include biochip analyzers, biochip immunoassays, clinical chemistry analyzers and diagnostic reagents among others. It offers …
  • Ctrip.Com International Ltd:企業の戦略・SWOT・財務分析
    Ctrip.Com International Ltd - Strategy, SWOT and Corporate Finance Report Summary Ctrip.Com International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Strauss Group Ltd.:企業の戦略・SWOT・財務情報
    Strauss Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Strauss Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • PTC Therapeutics Inc (PTCT)-製薬・医療分野:企業M&A・提携分析
    Summary PTC Therapeutics Inc (PTC Therapeutics) discovers, develops, and commercializes orally active small molecule therapeutics that target post transcriptional control. The company's pipeline products include an orally administered small-molecule targeted at genetic disorders due to a nonsense mu …
  • Formula Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Formula Pharmaceuticals Inc (Formula Pharmaceuticals) is an oncology company that develops chimeric antigen receptor (CAR) immunotherapy for oncology and autoimmune diseases. The company’s pipeline products include CIK-CAR.CD19, used as B-lymphocyte surface antigen; CIK-CAR.CD33, used for th …
  • XBiotech Inc (XBIT):企業の財務・戦略的SWOT分析
    Summary XBiotech Inc (XBiotech) is a biopharmaceutical company that discovers, develops and commercialize therapeutic antibodies based proprietary technology. The company provides monoclonal antibodies treatment for various diseases. It’s lead product Xilonix, a therapeutic antibody being developed …
  • Sinovac Biotech Ltd (SVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Sinovac Biotech Ltd (Sinovac Biotech) is a biopharmaceutical company that develops, manufactures and commercializes vaccines. The company’s products comprise healive, bilive, anflu, panflu and panflu, among others. Its healive is an inactivated hepatitis A vaccine. Sinovac Biotech’s bilive i …
  • B&G Foods, Inc.:企業の戦略・SWOT・財務情報
    B&G Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary B&G Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • PanOptica Inc-製薬・医療分野:企業M&A・提携分析
    Summary PanOptica Inc (PanOptica) is a biopharmaceutical company that develops new ocular therapies in the field of ophthalmology. The company concentrates on candidates that are at or near the investigational new drug application stage. It licenses and develops novel therapeutics that can improve e …
  • Cassava Sciences Inc (SAVA):企業の財務・戦略的SWOT分析
    Cassava Sciences Inc (SAVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Transelectrica SA:企業の発電所・SWOT分析2018
    Transelectrica SA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Daelim Industrial Co Ltd:企業の戦略・SWOT・財務情報
    Daelim Industrial Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Daelim Industrial Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Enauta Participacoes SA (QGEP3):企業の財務・戦略的SWOT分析
    Summary Enauta Participacoes SA (Enauta), a subsidiary of Queiroz Galvao Group, is an oil and gas company that explores, develops and produces oil and gas properties. The company's exploration properties include Santos Basin, Espirito Santo Basin, Camamu-Almada Basin, Sergipe-Alagoas Basin, Pernambu …
  • Westlake Chemical Corp (WLK):企業の財務・戦略的SWOT分析
    Summary Westlake Chemical Corp (Westlake Chemical) is a chemical company that manufactures and distributes petrochemicals, plastics and building products. The company offers products such as olefins, vinyls, styrene, polyethylene, epolene polymers, and others. It manufactures two primary petrochemic …
  • Teachers Mutual Bank Ltd:企業の戦略的SWOT分析
    Teachers Mutual Bank Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆